|
|
Article: ID Biomedical Corp.: Senior Vaccine Development Scientist, Dr. Mark Reddish, Joins ID Biomedical Subsidiary.
- Article from:
- Business Wire
- Article date:
- January 14, 1998
CopyrightCOPYRIGHT 1998 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jan. 14, 1998--ID BIOMED. (TSE:IDB.) (NASDAQ:IDBEF) ID Biomedical Corporation announced today that Dr. Mark Reddish, Ph.D. has been appointed Vice President, Product Development of its subsidiary company, ID Vaccine Corporation, based in Seattle, WA.
Dr. Reddish will join the team of industry specialists that is being assembled by ID Vaccine to advance the development of its vaccine products.
Todd Patrick, President of ID Vaccine, said , "Dr. Reddish will add considerable industry experience and expertise to ID Vaccine's product development team as we prepare for human testing of our group A ...